SCHEMBL14884167

SCHEMBL14884167

CC1(C)OB(c2ccc3ccc4c(ccc5cccnc54)c3n2)OC1(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCR1 P32246 4/20 0.42
▸ CCR8 P51685 4/20 0.42
▸ L3MBTL1 Q9Y468 4/20 0.42
▸ CCR5 P51681 3/20 0.42
▸ LMNA P02545 4/20 0.42
▸ KDM4E B2RXH2 4/20 0.42
▸ MAPT P10636 4/20 0.42
▸ TDP1 Q9NUW8 3/20 0.42
▸ MMP2 P08253 2/20 0.42
▸ TSHR P16473 2/20 0.42
▸ HTT P42858 2/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ HSP90AA1 P07900 2/20 0.42
▸ GMNN O75496 1/20 0.42
▸ TP53 P04637 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ MMP9 P14780 1/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ NFKB1 P19838 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14884190 0.99 CCR1 (0.41) CCR1CCR8L3MBTL1CCR5LMNA
SCHEMBL14884189 0.91 CCR1 (0.37) CCR1CCR8L3MBTL1CCR5LMNA
SCHEMBL14884176 0.91 CCR1 (0.37) CCR1CCR8L3MBTL1CCR5LMNA
SCHEMBL16026600 0.90 CCR1 (0.50) CCR1CCR8L3MBTL1CCR5LMNA
SCHEMBL14884171 0.87 ALDH1A1 (0.36) CCR1CCR8L3MBTL1CCR5LMNA
SCHEMBL14884183 0.86 MAPT (0.42) CCR1CCR8L3MBTL1CCR5LMNA
SCHEMBL14884192 0.84 CCR1 (0.38) CCR1CCR8L3MBTL1CCR5LMNA
SCHEMBL22963565 0.84 HPRT1 (0.41) L3MBTL1LMNAMAPTTDP1TSHR
SCHEMBL31577401 0.84 HPRT1 (0.41) L3MBTL1LMNAMAPTTDP1TSHR
SCHEMBL14884174 0.84 ALDH1A1 (0.38) CCR1CCR8L3MBTL1CCR5LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9005777-B2 Heterocyclic compound, organic light-emitting diode including the heterocyclic compound, and flat display device including the organic light-emitting diode SAMSUNG DISPLAY CO., LTD. (KR) 2015-04-14 — — US disclosed
US-9005777-B2 Heterocyclic compound, organic light-emitting diode including the heterocyclic compound, and flat display device including the organic light-emitting diode SAMSUNG DISPLAY CO., LTD. (KR) 2015-04-14 — — US disclosed
US-20130099206-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE INCLUDING THE HETEROCYCLIC COMPOUND, AND FLAT DISPLAY DEVICE INCLUDING THE ORGANIC LIGHT-EMITTING DIODE SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2013-04-25 — — US disclosed
US-20130099206-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE INCLUDING THE HETEROCYCLIC COMPOUND, AND FLAT DISPLAY DEVICE INCLUDING THE ORGANIC LIGHT-EMITTING DIODE SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2013-04-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130099206-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE INCLUDING THE HETEROCYCLIC COMPOUND, AND FLAT DISPLAY DEVICE INCLUDING THE ORGANIC LIGHT-EMITTING DIODE DRD1, HTR1D, DRD4 CCR1 1769/4885CCR8 2271/4885L3MBTL1 271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback